Advertisement

General Management

  • Moherndran ArcharyEmail author
Chapter
  • 18 Downloads

Abstract

Antiretroviral treatment (ART) has dramatically increased the life expectancy of people living with HIV, with significant decreases in the HIV-associated mortality in all age groups. While there is still more work to be done in improving access to ART in key populations, clinical care of HIV infected children and adolescents is shifting from preventing mortality to improving the general wellbeing and preventing morbidity. These changes require integration of paediatric HIV care into routine treatment and preventative services, and the management of HIV to be similar to other chronic medical illness. In this chapter we explore the non-ART management of HIV infected children.

Keywords

HIV HIV exposed HIV infected Immunization Routine care 

References

  1. 1.
    Millar JR, Mvo Z, Bengu N, Fillis R, Sprenger K, Matthews PC, et al. Increasing diagnostic uncertainties in children with in utero HIV infection. Pediatr Infect Dis J. 2019;38(8):e166–8.  https://doi.org/10.1097/INF.0000000000002315.CrossRefPubMedGoogle Scholar
  2. 2.
    Bispo S, Chikhungu L, Rollins N, Siegfried N, Newell ML. Postnatal HIV transmission in breastfed infants of HIV-infected women on ART: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21251. https://doi.org/doi:10.7448/IAS.20.1.21251.CrossRefGoogle Scholar
  3. 3.
    World Health Organisation. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. 2018a. Available from: https://apps.who.int/iris/bitstream/handle/10665/260233/9789241550239-eng.pdf?sequence=1. Accessed on 26 May 2019.
  4. 4.
    World Health Organisation. Guidelines on HIV and infant feeding. Principles and recommendations for infant feeding in the context of HIV and a summary of evidence. 2010. Available from: https://www.unicef.org/aids/files/hiv_WHO_guideline_on_HIV_and_IF.pdf. Accessed on 2 June 2019.
  5. 5.
    World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. 2nd ed. 2016. Available from: https://www.who.int/hiv/pub/arv/arv-2016/en/. Accessed on 02 June 2019.
  6. 6.
    World Health Organisation. Revised BCG vaccination guidelines for children with HIV infection. 2007. Available from: https://www.who.int/immunization/sage/BCGvaccination_revsd_13Apr_07.pdf. Accessed on 2 June 2019.
  7. 7.
    World Health Organisation. Guidelines for an integrated approach to the nutritional care of HIV-infected children (6 months–14 years). Preliminary version for country introduction. 2009. Available from: https://apps.who.int/iris/bitstream/handle/10665/44043/9789241597524_eng_Handbook.pdf;jsessionid=D0AC734EE84DF006DA6E4279DBEE8814?sequence=1. Accessed on 26 May 2019.
  8. 8.
    World Health Organisation. Guideline: updates on the management of severe acute malnutrition in infants and children. 2013. Available from: https://apps.who.int/iris/bitstream/handle/10665/95584/9789241506328_eng.pdf?sequence=1. Accessed on 26 May 2019.
  9. 9.
    Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi K, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364(9448):1865–71.  https://doi.org/10.1016/S0140-6736(04)17442-4.CrossRefPubMedGoogle Scholar
  10. 10.
    World Health Organisation. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults recommendations for a public health approach. 2006. Available from: https://www.who.int/hiv/pub/guidelines/ctxguidelines.pdf?ua=1. Accessed on 26 May 2019.
  11. 11.
    Coutsoudis A, Coovadia HM, Kindra G. Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries. Bull World Health Organ. 2010;88(12):949–50.  https://doi.org/10.2471/BLT.10.076422.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    World Health Organisation. HIV and infant feeding in emergencies: operational guidance: the duration of breastfeeding and support from health services to improve feeding practices among mothers living with HIV. 2018b. Available from: http://www.who.int/iris/handle/10665/272862. Accessed on 2 June 2019.
  13. 13.
    Swindells S, Ramchandani R, Gupta A, Benson C, Leon-Cruz J, Mwelase N, et al. One month of Rifapentine plus isoniazid to prevent HIV-related tuberculosis. N Engl J Med. 2019;380(11):1001–11.  https://doi.org/10.1056/NEJMoa1806808.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    National Institutes of Health. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2018. Department of Health and Human Services. Available from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed on 23 May 2019.
  15. 15.
    National Institutes of Health. Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. 2013. Department of Health and Human Services. Available from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/oi_guidelines_pediatrics.pdf. Accessed on 2 June 2019.
  16. 16.
    Menson EN, Mellado MJ, Bamford A, Castelli G, Duiculescu D, Marczyńska M, et al. Guidance on vaccination of HIV-infected children in Europe. HIV Med. 2012;13(6):333–6.  https://doi.org/10.1111/j.1468-1293.2011.00982.x.CrossRefPubMedGoogle Scholar
  17. 17.
    Dlamini SK, Madhi SA, Muloiwa R, von Gottberg A, Moosa M-Y, Meiring ST, et al. Guidelines for the vaccination of HIV-infected adolescents and adults in South Africa. S Afr J HIV Med. 2018;19(1):a839.  https://doi.org/10.4102/sajhivmed.v19i1.839.CrossRefGoogle Scholar
  18. 18.
    Vreeman RC, McCoy BM, Lee S. Mental health challenges among adolescents living with HIV. J Int AIDS Soc. 2017;20(Suppl 3):21497.  https://doi.org/10.7448/IAS.20.4.21497.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Nassen R, Donald K, Walker K, Paruk S, Vujovic M, Duncan W, et al. Management of mental health disorders and central nervous system sequelae in HIV-positive children and adolescents: guideline. Southern African J HIV Med. 2014;15(3):81–96.  https://doi.org/10.7196/SAJHIVMED.1091.CrossRefGoogle Scholar
  20. 20.
    Hodgson TA, Rachanis CC. Oral fungal and bacterial infections in HIV-infected individuals: an overview in Africa. Oral Dis. 2002;8(Suppl 2):80–7.  https://doi.org/10.1034/j.1601-0825.2002.00017.x.CrossRefPubMedGoogle Scholar
  21. 21.
    Rwenyonyi CM, Kutesa A, Muwazi L, Okullo I, Kasangaki A, Kekitinwa A. Oral manifestations in HIV/AIDS-infected children. Eur J Dent. 2011 Jul;5(3):291–8.CrossRefGoogle Scholar
  22. 22.
    Govender NP, Roy M, Oladoyinbo S, et al. Phased implementation of screening for cryptococcal disease in South Africa. S Afr Med J 2012;102(12):914–917. http://dx.doi.org/ 10.7196/samj.6228.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Paediatrics and Child HealthKing Edward VIII Hospital, Nelson R Mandela School of Medicine, UKZNDurbanSouth Africa

Personalised recommendations